WallStSmart

Colgate-Palmolive Company (CL)vsBeauty Health Co (SKIN)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Colgate-Palmolive Company generates 6922% more annual revenue ($20.80B vs $296.12M). CL leads profitability with a 10.0% profit margin vs -2.0%. SKIN appears more attractively valued with a PEG of 0.93. CL earns a higher WallStSmart Score of 58/100 (C).

CL

Buy

58

out of 100

Grade: C

Growth: 4.0Profit: 8.5Value: 4.7Quality: 5.5
Piotroski: 4/9Altman Z: 4.21

SKIN

Hold

44

out of 100

Grade: D

Growth: 2.7Profit: 2.0Value: 6.0Quality: 4.5
Piotroski: 6/9Altman Z: -0.38
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

CLUndervalued (+5.5%)

Margin of Safety

+5.5%

Fair Value

$98.11

Current Price

$93.49

$4.62 discount

UndervaluedFair: $98.11Overvalued

Intrinsic value data unavailable for SKIN.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CL4 strengths · Avg: 9.3/10
Return on EquityProfitability
36.4%10/10

Every $100 of equity generates 36 in profit

Altman Z-ScoreHealth
4.2110/10

Safe zone — low bankruptcy risk

Market CapQuality
$73.56B9/10

Large-cap with strong market position

Operating MarginProfitability
20.9%8/10

Strong operational efficiency at 20.9%

SKIN2 strengths · Avg: 9.0/10
Price/BookValuation
1.5x10/10

Reasonable price relative to book value

PEG RatioValuation
0.938/10

Growing faster than its price suggests

Areas to Watch

CL4 concerns · Avg: 3.0/10
PEG RatioValuation
1.624/10

Expensive relative to growth rate

P/E RatioValuation
35.1x4/10

Premium valuation, high expectations priced in

Price/BookValuation
519.4x2/10

Trading at 519.4x book value

EPS GrowthGrowth
-5.9%2/10

Earnings declined 5.9%

SKIN4 concerns · Avg: 2.8/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$109.36M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-10.9%2/10

ROE of -10.9% — below average capital efficiency

Revenue GrowthGrowth
-6.7%2/10

Revenue declined 6.7%

Comparative Analysis Report

WallStSmart Research

Bull Case : CL

The strongest argument for CL centers on Return on Equity, Altman Z-Score, Market Cap.

Bull Case : SKIN

The strongest argument for SKIN centers on Price/Book, PEG Ratio. PEG of 0.93 suggests the stock is reasonably priced for its growth.

Bear Case : CL

The primary concerns for CL are PEG Ratio, P/E Ratio, Price/Book. Debt-to-equity of 54.99 is elevated, increasing financial risk.

Bear Case : SKIN

The primary concerns for SKIN are EPS Growth, Market Cap, Return on Equity. Debt-to-equity of 6.65 is elevated, increasing financial risk.

Key Dynamics to Monitor

CL profiles as a value stock while SKIN is a turnaround play — different risk/reward profiles.

SKIN carries more volatility with a beta of 1.08 — expect wider price swings.

CL is growing revenue faster at 8.4% — sustainability is the question.

CL generates stronger free cash flow (609M), providing more financial flexibility.

Bottom Line

CL scores higher overall (58/100 vs 44/100). Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Colgate-Palmolive Company

CONSUMER DEFENSIVE · HOUSEHOLD & PERSONAL PRODUCTS · USA

Colgate-Palmolive Company is an American multinational consumer products company headquartered on Park Avenue in Midtown Manhattan, New York City. It specializes in the production, distribution and provision of household, health care, personal care and veterinary products.

Visit Website →

Beauty Health Co

CONSUMER DEFENSIVE · HOUSEHOLD & PERSONAL PRODUCTS · USA

Edge Systems, LLC designs, develops, manufactures, markets and sells aesthetic products and technologies. The company is headquartered in Signal Hill, California with a location in Long Beach, California.

Want to dig deeper into these stocks?